I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| progenitor cell | 6 studies | 32% ± 17% | |
| T cell | 6 studies | 42% ± 19% | |
| epithelial cell | 6 studies | 29% ± 11% | |
| plasmablast | 5 studies | 49% ± 12% | |
| B cell | 5 studies | 44% ± 18% | |
| transit amplifying cell | 5 studies | 40% ± 15% | |
| erythroblast | 5 studies | 52% ± 21% | |
| natural killer cell | 5 studies | 36% ± 14% | |
| CD8-positive, alpha-beta T cell | 5 studies | 47% ± 21% | |
| endothelial cell | 4 studies | 21% ± 3% | |
| pro-B cell | 4 studies | 27% ± 3% | |
| erythrocyte | 4 studies | 52% ± 28% | |
| CD4-positive, alpha-beta T cell | 4 studies | 54% ± 19% | |
| fibroblast | 3 studies | 19% ± 2% | |
| connective tissue cell | 3 studies | 27% ± 10% | |
| macrophage | 3 studies | 25% ± 5% | |
| monocyte | 3 studies | 21% ± 1% | |
| neural crest cell | 3 studies | 46% ± 12% | |
| plasma cell | 3 studies | 30% ± 8% | |
| granulocyte monocyte progenitor cell | 3 studies | 53% ± 25% | |
| hematopoietic precursor cell | 3 studies | 44% ± 26% | |
| megakaryocyte-erythroid progenitor cell | 3 studies | 36% ± 10% | |
| germinal center B cell | 3 studies | 34% ± 13% |
